Table 3.
Physically active | Non active | |||
---|---|---|---|---|
Functional limitation | ADL/IADLs impairment | Functional limitation | ADL/IADLs impairment | |
PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | |
Total sample | ||||
Model 1* | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.32 (1.05–1.64) | 0.95 (0.66–1.36) | 1.26 (1.00–1.58) | 0.96 (0.74–1.26) |
Obese | 2.52 (1.85–3.43) | 1.38 (0.86–2.19) | 2.12 (1.74–2.58) | 1.31 (1.01–1.69) |
Model 2╪ | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.47 (1.17–1.85) | 0.92 (0.64–1.34) | 1.25 (0.97–1.62) | 0.84 (0.62–1.13) |
Obese | 2.71 (2.00–3.67) | 1.16 (0.77–1.74) | 1.99 (1.58–2.50) | 1.03 (0.79–1.34) |
Women | ||||
Model 1* | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.74 (1.24–2.43) | 1.65 (0.94–2.89) | 1.43 (1.05–1.94) | 0.87 (0.63–1.20) |
Obese | 4.13 (2.71–6.30) | 2.39 (1.99–4.79) | 2.48 (1.82–3.38) | 1.40 (1.03–1.92) |
Model 2╪ | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.82 (1.26–2.63) | 1.72 (1.01–2.93) | 1.374 (0.97–1.94) | 0.77 (0.53–1.13) |
Obese | 3.96 (2.53–6.21) | 1.86 (0.97–3.56) | 2.42 (1.65–3.56) | 1.16 (0.81–1.65) |
Men | ||||
Model 1* | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.06 (0.74–1.53) | 0.54 (0.32–0.93) | 1.13 (0.80–1.61) | 1.08 (0.69–1.68) |
Obese | 1.59 (1.04–2.44) | 0.73 (0.42–1.29) | 1.76 (1.23–2.52) | 1.17 (0.81–1.69) |
Model 2╪ | ||||
Normal | Reference | Reference | Reference | Reference |
Overweight | 1.06 (0.75–1.49) | 0.49 (0.29–0.84) | 1.03 (0.69–1.55) | 0.90 (0.56–1.46) |
Obese | 1.64 (1.06–2.54) | 0.67 (0.41–1.06) | 1.42 (0.91–2.23) | 0.87 (0.59–1.28) |
Model 1 is unadjusted
Model 2 is adjusted for education, age and comorbidity